FAILURE OF ATOVAQUONE IN THE TREATMENT OF CEREBRAL TOXOPLASMOSIS

被引：4

作者：

DURAND, JM

CRETEL, E

BAGNERES, D

GUILLEMOT, E

KAPLANSKI, G

SOUBEYRAND, J

机构：

来源：

AIDS | 1995年 / 9卷 / 07期

关键词：

D O I：

10.1097/00002030-199507000-00022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：812 / 813

页数：2

相关论文

共 6 条

[1] THE ACTIVITY OF ATOVAQUONE-(566C80) IN MURINE TOXOPLASMOSIS IS MARKEDLY AUGMENTED WHEN USED IN COMBINATION WITH PYRIMETHAMINE OR SULFADIAZINE
ARAUJO, FG
LIN, T
REMINGTON, JS
[J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (02) : 494 - 497
[2] ATOVAQUONE - A REVIEW
HAILE, LG
FLAHERTY, JF
[J]. ANNALS OF PHARMACOTHERAPY, 1993, 27 (12) : 1488 - 1494
[3] EFFICACY OF ATOVAQUONE IN TREATMENT OF TOXOPLASMOSIS IN PATIENTS WITH AIDS
KOVACS, JA
[J]. LANCET, 1992, 340 (8820) : 637 - 638
[4] TREATMENT OF CENTRAL NERVOUS-SYSTEM TOXOPLASMOSIS WITH PYRIMETHAMINE SULFADIAZINE COMBINATION IN 35 PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME - EFFICACY OF LONG-TERM CONTINUOUS THERAPY
LEPORT, C
RAFFI, F
MATHERON, S
KATLAMA, C
REGNIER, B
SAIMOT, AG
MARCHE, C
VEDRENNE, C
VILDE, JL
[J]. AMERICAN JOURNAL OF MEDICINE, 1988, 84 (01) : 94 - 100
[5] TOXOPLASMIC ENCEPHALITIS
LUFT, BJ
REMINGTON, JS
[J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (01) : 1 - 6
[6] MANAGEMENT OF TOXOPLASMOSIS
STGEORGIEV, V
[J]. DRUGS, 1994, 48 (02) : 179 - 188